SUMMARY A longitudinal evaluation was carried out of the clinical, infective, and immunological progress of 34 children (who were aged 6 to 68 months-mean 25 months at the time of writing) born to 31 mothers infected with human immunodeficiency virus (HIV), over a mean observation period of 13.4 months. Clinical symptoms, not always clearly related to HIV became apparent in 11 children, and preceding immune abnormalities were documented in two of them. In eight children culture for HIV was positive, and six of these were symptomatic. No cancers were diagnosed and none of the children died. Immune abnormalities including hypergammaglobulinaemia, IgG subclass deficiency, low serum IgA concentration, antibody deficiency, a decrease in the number of CD4+(T helper) cells, and defective cellular responses to antigens, were found in seven of the children in whom culture for HIV was positive; in two of four who had symptoms and in all four who were symptom free and in whom culture was negative for HIV but in whom HIV antibodies persisted and who were older than 15 months; and in three of nine who were symptom free and in whom culture was negative with loss of HIV antibodies.
Infants born to mothers infected with human immunodeficiency virus (HIV) may acquire the virus in utero or perinatally.1 In contrast with adults, in whom infection with HIV can be diagnosed simply by detection of antibodies or antigens specific for HIV, serological diagnosis in infants is more difficult because maternal antibodies specific for HIV cross the placenta. Furthermore, detection of specific IgM or IgA, or both, which could be of infant origin, may merely reflect the contact of the child with noninfectious HIV antigens crossing the placenta; it is also prone to technical problems. Concentrations of the immunoglobulins A, G, and M were determined by nephelometry, and IgG subclass concentrations by immunodiffusion with specific polyclonal antibodies (Central Laboratory of the Netherlands Red Cross). Infants who had been followed up since birth were immunised at the ages of 3, 4, and 5 months with diphtheria toxoid, tetanus toxoid, and inactivated polio virus vaccine. To assess the humoral immune response, antitetanus toxoid antibodies were measured by an enzyme linked immunosorbent assay (ELISA) before and four weeks after the last immunisation. Infants entering the study after their primary immunisation but with antitetanus toxoid antibodies below 1000 U/l were given boosters of tetanus toxoid and the antibody response was reevaluated four weeks later. Antibody deficiency was defined as the lack of adequate antibody response (<1000. U/l) four weeks after immunisation.
Cellular immunity was assessed by measuring lymphocyte subpopulations using specific monoclonal antibodies (Becton Dickinson) for surface IgM During coculture, cells were kept in RPMI 1640 containing 20% fetal bovine serum and interleukin 2 at a concentration of 2x104 U/l. Cells were refed every three to four days. Culture fluids were harvested at seven day intervals, pelleted at 100 000 g, and assayed for reverse transcriptase activity6 and HIV antigen. Alternatively, the patients' mononuclear cells were prestimulated for two days with phytohaemagglutinin containing culture medium, before coculture with the target cells as described.7
Results
From June 1986 to May 1988, 34 children (including two monozygous twin pairs and two siblings) born to 31 mothers were enrolled in the study (figure). The median age of the children at the time of writing was 25 months (range 6-68 months) and the mean observation period 13-4 months (range 3-24 months). Serology for HIV had been done for the mothers of 25 children before or at delivery. Three of the nine children whose mothers had not group.bmj.com on June 22, 2017 -Published by http://adc.bmj.com/ Downloaded from cases the age at which they lost their antibodies is unknown because they entered the study when they were already seronegative (cases 19 and 29).
Nine children who were negative on culture for HIV (and one in whom HIV culture could not be done) had persisting IgG anti-HIV after the age of 15 months (age range at last test 18-37 months). Seven of these 10 children (cases 5, 9-11, 15, 20, and 32) had immune abnormalities, two of whom had symptoms (cases 15 and 20). Of the three children without immune abnormalities (cases 3, 14, and 21) two had symptoms (cases 3 and 14) .
In all eight children who were positive on culture for HIV, anti-HIV antibodies were present. Finally, the remaining eight (cases 23-28, 30, and 34) of the 34 children were younger than 15 months and still seropositive for HIV. One of them had symptoms, probably related to congenital toxoplasmosis (case 27).
The presence of HIV specific IgM antibodies was inconsistent. They were detected in five patients who were positive on culture for HIV (cases 1, 2, 4, 6, and 16); three of them lost the IgM at ages 12, 20, and 38 months, respectively. Specific IgM antibodies were also present in eight children who were negative on culture (cases 3, 10, 11, 14, 15, 20, 25, and 30) at ages 3, 3, 5, 9, 15, 15, 25, and 32 months, respectively. In three of them the result had been negative at earlier determinations (cases 10, 11, and 15). Five of the eight children negative on culture for HIV (cases 3, 11, 14, 25, and 30) lost the IgM later.
Specific IgA antibodies against HIV antigens were found inconsistently in three children who were positive on culture (cases 1, 4, and 6) and five who were negative on culture (cases 14, 21, 25, 27, and 30).
CLINICAL SIGNS
The symptoms and their age of onset were noted in 11 children and are summarised in table 2. Two patients had AIDS (cases 4 and 6), three the lymphadenopathy syndrome (cases 1, 20, and 31), and in six children the symptoms may well have been caused by HIV infection (cases 3, 7, 14, 15, 27, and 33). Two of these six were positive on culture for HIV, a 68 month old girl and a 6 month old boy.
He was hyperexcitable at the age of 3 months when his immune state still had to be assessed. A further three of the six children were older than 15 months and met the Centers for Disease Control criteria of HIV infection because of their seropositivity.89 The sixth child presented with spastic hemiparesis (case 31) that was most probably due to congenital toxoplasmosis (serological data not shown). His foster parents refused further investigations.
Symptoms that may not have been caused by HIV occurred in one girl with humoral and cellular immune abnormalities and a positive culture for HIV (case 7), and in three children without immune abnormalities, two of whom met the Centers for Disease Control criteria for HIV infection8 9 (cases 3 and 14), and one in whom HIV infection was still not certain (case 27). At the time of writing there had been no cancers and no deaths.
TREATMENT
Daily antimicrobial prophylaxis with co-trimoxazole (40 mg/kg/day) and ketoconazole (5 mg/kg/day) and monthly infusions of intravenous gammaglobulin (0.4 g/kg) were started in five immunodeficient children with symptoms (cases 1, 4, 6, 20, and 31) at the ages of 45, 7, 10, 34, and 9 months, respectively. The favourable effect of this regimen in the two patients with AIDS and encephalopathy has been reported recently. 
